Malignant Fallopian Tube Neoplasm
NCI Definition: A primary or metastatic malignant neoplasm that affects the fallopian tube. Representative examples include carcinoma, carcinosarcoma, and leiomyosarcoma. 
Malignant fallopian tube neoplasms most frequently harbor alterations in TP53, NOTCH3, CCNE1, BRD4, and SMARCA4 .
TP53 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, TP53 Exon 8 Mutation, and TP53fs are the most common alterations in malignant fallopian tube neoplasm .
There is 1 clinical trial for malignant fallopian tube neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains malignant fallopian tube neoplasm as an inclusion criterion, 1 is phase 1 (1 open).
Everolimus and niraparib are the most common interventions in malignant fallopian tube neoplasm clinical trials.
1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.